Clinical Trial

Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine the effect to which Suprathel® (Polymedics Innovations GmbH, Denkendorf, Germany) can reduce the need for grafting compared to Standard of Care (SoC). Furthermore, the study intends to evaluate if Suprathel® allows for a reduction of reduction of pain, infection, provider workload, scar development and costs compared to SoC.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-14
notable Primary completion pushed: 2025-12-29 -> 2026-12-09 2026-08-14
minor Completion pushed: 2026-06-29 -> 2026-12-09 2026-08-14
Trial Details
NCT Number NCT05462860
Lead Sponsor The Metis Foundation
Conditions Wound of Skin, Burns
Enrollment 21 participants
Start Date 2024-09-18
Primary Completion 2026-12-09 (estimated)
Study Completion 2026-12-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-13